獣医用医薬品の受託製造・研究市場規模、シェア、動向、2031年までの世界予測

獣医用医薬品の受託製造・研究市場は、2026年の63億8,000万米ドルから2031年には92億4,000万米ドルへと、年平均成長率（CAGR）7.7%に達するとMarketsandMarketsでは予測しています。この市場成長は、獣医用医薬品開発、バイオ医薬品製造、精密動物医療の未来を形作るいくつかの重要な要因によって牽引されています。

この成長の大きな原動力は、動物用医薬品企業が製品パイプラインの加速、社内コストの削減、そして生物製剤、ワクチン、高度製剤といった複雑な治療薬に関する専門知識の活用を目指す中で、アウトソーシングによる開発・製造サービスへの需要が高まっていることです。獣医療業界がより標的を絞ったデータ駆動型治療アプローチへと移行するにつれ、高品質な研究、分析試験、そしてGMP準拠の製造に対するニーズが急速に高まっています。さらに、ペットや家畜における慢性疾患、感染症、人獣共通感染症の負担増大は、より迅速かつ効率的な研究開発（R&D）プロセスへの需要を押し上げています。CDMO（医薬品受託製造開発機関）とCRO（医薬品開発業務受託機関）は、拡張可能な製造、ハイスループットスクリーニング、高度な研究能力を提供することで、こうしたニーズを満たす上で重要な役割を果たしています。リアルタイムモニタリングツール、デジタルワークフロー、臨床試験管理の改善など、獣医療における近代化への継続的な流れは、専門的なアウトソーシングパートナーへの依存度をさらに高めています。

予測モデリングへのAIの統合、バイオプロセスの自動化、高度な分析プラットフォームの開発といった技術革新も、市場成長を牽引しています。これらのイノベーションは、精度を高め、開発期間を短縮し、前臨床、臨床、商業段階にわたるアウトソーシングサービスの適用範囲を拡大します。全体として、業界需要の高まり、技術の進歩、そして専門性とアウトソーシングされた専門知識への移行の拡大が、獣医用医薬品受託製造・研究市場の力強く持続的な成長を牽引しています。

調査範囲

本市場調査は、獣医用医薬品受託製造・研究市場を様々なセグメントに分けて分析しています。サービス、製品タイプ、動物種、エンドユーザー、地域別に市場規模と成長可能性を推定することを目的としています。また、主要企業の詳細な競合分析、企業プロファイル、製品および事業内容に関する重要な考察、最近の動向、主要な市場戦略についても詳述しています。

本レポートを購入する理由

本レポートは、既存企業はもちろん、新規参入企業や中小企業が市場動向を理解し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下に概説する5つの戦略のうち、1つ以上を実行することができます。

本レポートでは、以下の点について考察します。

動物医療費の増加、獣医用生物製剤の複雑化、GMP、バイオセキュリティ、環境コンプライアンスに関する規制負担の増大といった主要な推進要因、限られた専門インフラ、長い承認期間、世界的な規制の多様性といった制約要因、新興市場への地理的拡大、デジタルCROサービスといった機会、そして臨床試験参加者の募集の難しさ、無菌製剤／生物製剤の製造能力の迅速な拡張の難しさといった課題を分析し、獣医用医薬品受託製造・研究市場の成長を後押しします。

• 製品開発／イノベーション：獣医用医薬品受託製造・研究市場における今後の技術やサービス展開に関する詳細な情報を提供します。
• 市場開発：有望な新興市場に関する包括的な情報を提供します。本レポートは、地域別の様々なタイプの獣医用医薬品受託製造・研究（CDMO）および医薬品開発業務受託（CRO）サービス市場を分析しています。
• 市場の多様化：獣医用医薬品受託製造・研究市場におけるサービス、未開拓地域、最新動向、投資に関する包括的な情報を提供します。
• 競合評価：獣医用医薬品受託製造・研究市場における主要企業の市場シェア、戦略、サービス、流通ネットワーク、製造能力を詳細に評価します。

Report Description

The veterinary contract manufacturing & research market is expected to grow from USD 6.38 billion in 2026 to USD 9.24 billion by 2031, at a CAGR of 7.7%. The market growth is driven by several key factors shaping the future of veterinary drug development, biologics manufacturing, and precision animal health.

A major driver of this growth is the increasing demand for outsourced development and manufacturing services as animal health companies seek to accelerate product pipelines, reduce internal costs, and access specialized expertise for complex therapeutics such as biologics, vaccines, and advanced formulations. As the veterinary industry shifts toward more targeted, data-driven treatment approaches, the need for high-quality research, analytical testing, and GMP-compliant production is rapidly rising. Additionally, the growing burden of chronic, infectious, and zoonotic diseases in both companion and livestock animals is driving demand for faster and more efficient research and development (R&D) processes. CDMOs and CROs play a critical role in meeting this need by providing scalable manufacturing, high-throughput screening, and advanced study capabilities. The ongoing trend toward modernization in veterinary healthcare, including the adoption of real-time monitoring tools, digital workflows, and improved clinical trial management, further strengthens reliance on specialized outsourcing partners.

Technological advancements, including the integration of AI for predictive modeling, automation in bioprocessing, and the development of enhanced analytical platforms, also drive market growth. These innovations enhance accuracy, shorten development timelines, and expand the applications of outsourced services across preclinical, clinical, and commercial phases. Overall, rising industry demands, advancements in technology, and the growing shift toward specialized and outsourced expertise are driving strong and sustained growth in the veterinary contract manufacturing & research market.

“By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.”

The software & services segment is expected to see the highest growth in the veterinary contract manufacturing & research market, due to rising pet ownership, increasing spending on advanced treatments, and growing demand for innovative therapeutics for dogs and cats. Conditions such as cancer, obesity, allergies, and chronic diseases are becoming more prevalent in pets, driving the need for new drugs, biologics, and specialty formulations. Pet owners’ willingness to invest in premium care, coupled with the humanization of pets and expanding insurance coverage, is encouraging animal health companies to develop more complex products—leading to greater outsourcing of R&D, manufacturing, and clinical studies to CDMOs and CROs.

“By end user, the multinational animal-health companies segment accounted for the largest market share in 2024.”

In 2024, the veterinary clinics segment dominated the veterinary contract manufacturing & research market because they manage extensive product pipelines, operate globally regulated supply chains, and consistently invest in developing advanced therapeutics, vaccines, and diagnostics. Their broad portfolios and high production volumes create a strong need for specialized outsourcing partners to support formulation, scale-up, analytical testing, and clinical research. Additionally, these companies increasingly rely on CDMOs and CROs to accelerate time-to-market, expand manufacturing capacity, and access cutting-edge technologies, making them the primary contributors to overall market demand.

“The Asia Pacific region is projected to witness the highest growth rate during the forecast period.”

The Asia Pacific is expected to experience the highest growth in the veterinary contract manufacturing & research market, driven by rising livestock production, increasing pet ownership, and growing investment in animal health infrastructure across countries such as China, India, and Southeast Asia. The region is witnessing rapid expansion of veterinary pharmaceutical manufacturing, greater adoption of advanced biologics and diagnostics, and stronger government support for disease control and vaccination programs. Additionally, lower operational costs, improving regulatory frameworks, and the emergence of local CDMOs and CROs are attracting global animal health companies to outsource more research and manufacturing to APAC, driving its accelerated growth.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
• By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Multinational animal-health companies (59%), mid-sized / specialty animal-health firms (26%), and start-ups & veterinary biotech firms (15%)
• By Designation: R&D directors/heads of research (47%), product development & innovation managers (22%), regulatory affairs managers/directors (15%), and others (16%)
• By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the veterinary contract manufacturing & research market in various segments. It aims to estimate the market size and growth potential of this market by service, product type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

Analysis of key drivers (growth in animal health spending, increasing complexity of veterinary biologics and the increasing regulatory burden for GMP, biosecurity & environmental compliance.), restraints (limited specialized infrastructure and long approval timelines & regulatory diversity globally), opportunities (geographic expansion into emerging markets, digital CRO services), and challenges (difficulty in clinical trial recruitment and difficulty in scaling sterile/biologics capacity quickly) influencing the growth of the veterinary contract manufacturing & research market

• Product Development/Innovation: Detailed insights on upcoming technologies and service launches in the veterinary contract manufacturing & research market
• Market Development: Comprehensive information about lucrative emerging markets; the report analyzes the markets for various types of veterinary CDMO & CRO services across regions
• Market Diversification: Exhaustive information about services, untapped regions, recent developments, and investments in the veterinary contract manufacturing & research market
• Competitive Assessment: In-depth assessment of market shares, strategies, services, distribution networks, and manufacturing capabilities of the leading players in the veterinary contract manufacturing & research market

Table of Contents

1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.3 STUDY SCOPE 45
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 45
1.3.2 INCLUSIONS & EXCLUSIONS 46
1.3.3 YEARS CONSIDERED 47
1.4 MARKET STAKEHOLDERS 47
1.5 LIMITATIONS 48
2 EXECUTIVE SUMMARY 49
3 PREMIUM INSIGHTS 56
3.1 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET OVERVIEW 56
3.2 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE & COUNTRY (2025) 57
3.3 VETERINARY CROS MARKET: REGIONAL MIX 58
3.4 VETERINARY CDMOS MARKET: REGIONAL MIX 58
3.5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
GEOGRAPHIC GROWTH OPPORTUNITIES 59
3.6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
DEVELOPED VS. EMERGING ECONOMIES 60
4 MARKET OVERVIEW 61
4.1 INTRODUCTION 61
4.2 MARKET DYNAMICS 61
4.2.1 DRIVERS 62
4.2.1.1 Growth in animal health spending 62
4.2.1.2 Increasing complexity of veterinary biologics 62
4.2.1.3 Rising regulatory requirements for GMP, biosecurity, and environmental compliance 63
4.2.2 RESTRAINTS 63
4.2.2.1 Limited specialized infrastructure 63
4.2.2.2 Long approval timelines & regulatory diversity globally 64
4.2.3 OPPORTUNITIES 65
4.2.3.1 Geographic expansion into emerging markets 65
4.2.3.2 Digital CRO services 65
4.2.4 CHALLENGES 66
4.2.4.1 Challenges in clinical trial recruitment 66
4.2.4.2 Difficulty in scaling sterile/biologics capacity quickly 66
4.3 UNMET NEEDS & WHITE SPACES 67
4.3.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 67
4.3.2 WHITE SPACE OPPORTUNITIES 68
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 69
4.4.1 INTERCONNECTED MARKETS 69
4.4.2 CROSS-SECTOR OPPORTUNITIES 69
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 70
4.5.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 70
5 INDUSTRY TRENDS 71
5.1 PORTER’S FIVE FORCES ANALYSIS 71
5.1.1 THREAT OF NEW ENTRANTS 72
5.1.2 THREAT OF SUBSTITUTES 73
5.1.3 BARGAINING POWER OF SUPPLIERS 73
5.1.4 BARGAINING POWER OF BUYERS 74
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.2 MACROECONOMIC INDICATORS 75
5.2.1 INTRODUCTION 75
5.2.2 GDP TRENDS & FORECAST 75
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 76
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 76
5.3 SUPPLY CHAIN ANALYSIS 77
5.4 VALUE CHAIN ANALYSIS 78
5.5 ECOSYSTEM ANALYSIS 79
5.6 PRICING ANALYSIS 80
5.6.1 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023–2025 81
5.6.2 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY REGION, 2023–2025 81
5.6.2.1 Average selling price trend of small-molecule pharmaceuticals for API/drug substance manufacturing, by region, 2023−2025 82
5.6.2.2 Average selling price trend of small-molecule pharmaceuticals for fill-finish/drug product manufacturing, by region, 2023−2025 82
5.6.2.3 Average selling price trend of animal health biologics & vaccines for API/drug substance manufacturing, by region, 2023−2025 82
5.6.2.4 Average selling price trend of animal health biologics & vaccines for fill-finish/drug product manufacturing, by region, 2023−2025 83
5.7 KEY CONFERENCES & EVENTS, 2026–2027 83
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
5.9 INVESTMENT & FUNDING SCENARIO 85
5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS 86
5.10.1 END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS 86
5.10.2 END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB) 87
5.10.3 END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS 87
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS,
AND DIGITAL & AI ADOPTION 88
6.1 TECHNOLOGY ANALYSIS 88
6.1.1 KEY EMERGING TECHNOLOGIES 88
6.1.1.1 High-throughput in vitro & in vivo screening platforms 88
6.1.1.2 AI/ML platforms for drug discovery 88
6.1.2 COMPLEMENTARY TECHNOLOGIES 89
6.1.2.1 Laboratory automation, robotics, and smart QC systems 89
6.1.2.2 Stability, cold chain, and packaging optimization technologies 89
6.1.3 ADJACENT TECHNOLOGIES 90
6.1.3.1 Digital therapeutics & software-as-a-medical-device (SaMD) 90
6.1.3.2 Precision livestock technologies 90
6.2 TECHNOLOGY/PRODUCT ROADMAP 91
6.2.1 NEAR TERM (2025–2027) 91
6.2.2 MID TERM (2028–2030) 91
6.2.3 LONG TERM (2030+) 91
6.3 PATENT ANALYSIS 92
6.3.1 PATENT PUBLICATION TRENDS FOR VETERINARY PHARMACEUTICALS 92
6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 93
6.4 FUTURE APPLICATIONS 95
6.4.1 ADVANCED BIOLOGICS & VACCINE MANUFACTURING PLATFORMS 95
6.4.2 DIGITALIZED, DATA-RICH CLINICAL DEVELOPMENT USING AI, REMOTE MONITORING, AND REAL-WORLD DATA 95
6.4.3 GLOBALIZED, REGULATORY-READY DEVELOPMENT WITH HARMONIZED QUALITY & MANUFACTURING SYSTEMS 95
6.4.4 INNOVATIVE FORMULATION TECHNOLOGIES FOR LONG-ACTING, SPECIES-TAILORED, AND DIFFICULT-TO-DELIVER PRODUCTS 96
6.5 IMPACT OF AI/GENERATIVE AI ON VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 96
6.5.1 INTRODUCTION 96
6.5.2 MARKET POTENTIAL IN VETERINARY CONTRACT MANUFACTURING & RESEARCH ECOSYSTEM 96
6.5.3 AI USE CASES 97
6.5.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 97

7 SUSTAINABILITY & REGULATORY LANDSCAPE 99
7.1 REGIONAL REGULATIONS & COMPLIANCE 99
7.1.1 REGULATORY ANALYSIS 99
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
7.1.3 INDUSTRY STANDARDS 101
7.2 SUSTAINABILITY INITIATIVES 102
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY PRODUCTS 102
7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 102
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 102
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 104
8.1 KEY STAKEHOLDERS & BUYING CRITERIA 104
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
8.1.2 BUYING CRITERIA 105
8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 106
8.2.1 DECISION-MAKING PROCESS 106
8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 107
8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 107
8.2.4 MARKET PROFITABILITY 108
9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE 109
9.1 INTRODUCTION 110
9.2 CRO SERVICES 112
9.2.1 DISCOVERY & PRE-CLINICAL STUDIES 115
9.2.1.1 Growing use of discovery & pre-clinical studies to accelerate veterinary drug pipeline initiation 115
9.2.2 VETERINARY CLINICAL TRIALS 117
9.2.2.1 Growing dependence on veterinary clinical trials to validate safety and efficacy for regulatory approvals to boost market 117
9.2.3 ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE 119
9.2.3.1 Rising adoption of analytical & bioanalytical services to ensure high-quality, compliant veterinary products to fuel growth 119
9.2.4 REGULATORY AFFAIRS & CONSULTING 121
9.2.4.1 Increasing need for regulatory affairs & consulting to navigate complex global veterinary approval pathways to support growth 121
9.3 CDMO SERVICES 123
9.3.1 PROCESS API & FORMULATION DEVELOPMENT 126
9.3.1.1 Growing focus on process API & formulation development to optimize veterinary product performance to drive growth 126
9.3.2 MANUFACTURING 128
9.3.2.1 Increasing outsourcing of manufacturing to scale production of veterinary drugs and biologics 128
9.3.3 PACKAGING & LABELING 130
9.3.3.1 Rising dependence on packaging & labeling services to ensure regulatory-compliant product delivery to propel market 130
9.3.4 QUALITY/STABILITY & POST-MARKET SUPPORT 132
9.3.4.1 Expanding use of quality, stability, and post-market support to maintain lifecycle product compliance to boost market 132
10 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE 134
10.1 INTRODUCTION 135
10.2 MEDICINES 135
10.2.1 SMALL-MOLECULE PHARMACEUTICALS 138
10.2.1.1 API/Drug substance manufacturing 140
10.2.1.1.1 Growing focus on API manufacturing to support market growth 140
10.2.1.1.2 Global volume analysis of small-molecule pharmaceuticals market for API/drug substance manufacturing, by type, 2024–2031 (metric tons) 142
10.2.1.2 Fill-finish/drug product manufacturing 142
10.2.1.2.1 Increasing demand for fill-finish operations to fuel market growth 142
10.2.1.2.2 Global volume analysis of small-molecule pharmaceuticals market for fill-finish/drug product manufacturing, by type, 2024–2031 (ten thousand units) 144
10.2.2 ANIMAL HEALTH BIOLOGICS & VACCINES 144
10.2.2.1 API/Drug substance manufacturing 146
10.2.2.1.1 Rising demand for API/drug substance manufacturing to drive growth 146
10.2.2.1.2 Global volume analysis of animal health biologics & vaccines for API/drug substance manufacturing, by type, 2024–2031 (metric tons) 148
10.2.2.2 Fill-finish/drug product manufacturing 148
10.2.2.2.1 Rising dependence on fill-finish capabilities to fuel growth 148
10.2.2.2.2 Global volume analysis of animal health biologics & vaccines market for fill-finish/drug product manufacturing, by type, 2024–2031 (thousand units) 150
10.2.3 MEDICATED FEED & SUPPLEMENTS 150
10.2.3.1 Rising use of medicated feed & supplements to enhance livestock health and productivity 150
10.3 MEDICAL DEVICES 151
10.3.1 DIAGNOSTICS 154
10.3.1.1 Growing adoption of veterinary diagnostics to drive market growth 154
10.3.2 MONITORING SYSTEMS 156
10.3.2.1 Expanding utilization of monitoring systems to improve real-time animal health management to fuel growth 156

10.3.3 IMPLANTS 158
10.3.3.1 Increasing use of veterinary implants to support long-term treatment and orthopedic care to drive growth 158
11 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY ANIMAL TYPE 160
11.1 INTRODUCTION 161
11.2 COMPANION ANIMALS 161
11.2.1 DOGS 164
11.2.1.1 High adoption rates of dogs to drive market growth 164
11.2.2 CATS 166
11.2.2.1 Rising disease prevalence among cats to drive market 166
11.2.3 HORSES 168
11.2.3.1 Growing equine population to support market growth 168
11.2.4 OTHER COMPANION ANIMALS 170
11.3 LIVESTOCK ANIMALS 172
11.3.1 CATTLE 174
11.3.1.1 Growing consumption of meat to drive market 174
11.3.2 SWINE 176
11.3.2.1 Growing incidence of infectious diseases to drive market 176
11.3.3 POULTRY 178
11.3.3.1 Increasing demand for poultry meat to contribute to market growth 178
11.3.4 SHEEP & GOATS 180
11.3.4.1 Growing global demand for wool to drive market 180
11.3.5 OTHER LIVESTOCK ANIMALS 181
12 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER 183
12.1 INTRODUCTION 184
12.2 MULTINATIONAL ANIMAL HEALTH COMPANIES 184
12.2.1 INCREASED OUTSOURCING BY MULTINATIONAL ANIMAL HEALTH COMPANIES TO EXPAND GLOBAL PRODUCT DEVELOPMENT 184
12.3 MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS 186
12.3.1 RISING RELIANCE OF MID-SIZED & SPECIALTY ANIMAL HEALTH FIRMS ON CDMO/CRO PARTNERS TO BOOST PIPELINES 186
12.4 START-UPS & VETERINARY BIOTECH FIRMS 188
12.4.1 GROWING ENGAGEMENT OF START-UPS & VETERINARY BIOTECH FIRMS TO ACCESS ADVANCED DEVELOPMENT CAPABILITIES 188

13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY REGION 190
13.1 INTRODUCTION 191
13.2 NORTH AMERICA 192
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 193
13.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 193
13.2.3 NORTH AMERICA: VALUE ANALYSIS, 2024–2031 194
13.2.4 US 199
13.2.4.1 Rising pet population to drive demand 199
13.2.5 CANADA 204
13.2.5.1 Rising pet adoption rate to drive market 204
13.3 EUROPE 209
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 210
13.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 211
13.3.3 EUROPE: VALUE ANALYSIS, 2024–2031 212
13.3.4 GERMANY 216
13.3.4.1 Germany to dominate European market during forecast period 216
13.3.5 UK 221
13.3.5.1 Increasing pet ownership to drive market growth 221
13.3.6 FRANCE 227
13.3.6.1 Rising cases of zoonotic diseases to drive market growth 227
13.3.7 ITALY 232
13.3.7.1 Growing livestock population to support market growth 232
13.3.8 SPAIN 237
13.3.8.1 Increasing animal healthcare expenditure to drive market growth 237
13.3.9 NETHERLANDS 242
13.3.9.1 Increasing companion animal population to drive market growth 242
13.3.10 REST OF EUROPE 247
13.4 ASIA PACIFIC 252
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 252
13.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 253
13.4.3 ASIA PACIFIC: VALUE ANALYSIS, 2024–2031 255
13.4.4 CHINA 259
13.4.4.1 China to dominate APAC market during forecast period 259
13.4.5 JAPAN 264
13.4.5.1 Aging pet population to drive market 264
13.4.6 INDIA 269
13.4.6.1 Rising livestock population to boost market growth 269
13.4.7 AUSTRALIA 275
13.4.7.1 Rising livestock animal population and increasing pet ownership to support market growth 275
13.4.8 SOUTH KOREA 280
13.4.8.1 Increasing demand for preventive care and aging pet population to drive market 280
13.4.9 THAILAND 285
13.4.9.1 Increasing demand for preventive care and aging pet population to drive market 285
13.4.10 NEW ZEALAND 290
13.4.10.1 High biosecurity standards to drive market 290
13.4.11 REST OF ASIA PACIFIC 295
13.5 LATIN AMERICA 299
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 299
13.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 300
13.5.3 LATIN AMERICA: VALUE ANALYSIS, 2024–2031 301
13.5.4 BRAZIL 305
13.5.4.1 Brazil to dominate LATAM market due to rapidly increasing livestock population 305
13.5.5 MEXICO 310
13.5.5.1 Rising demand for animal-derived food products to contribute to market growth 310
13.5.6 ARGENTINA 315
13.5.6.1 Rising livestock population to fuel market growth 315
13.5.7 REST OF LATIN AMERICA 320
13.6 MIDDLE EAST & AFRICA 325
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 325
13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 326
13.6.3 MIDDLE EAST & AFRICA: VALUE ANALYSIS, 2024–2031 327
13.6.4 GCC COUNTRIES 331
13.6.4.1 Kingdom of Saudi Arabia (KSA) 336
13.6.4.1.1 Technological advancements & government initiatives to boost growth 336
13.6.4.2 United Arab Emirates (UAE) 341
13.6.4.2.1 Government support and high livestock population to fuel UAE’s market growth 341
13.6.4.3 Rest of GCC Countries 346
13.6.5 REST OF MIDDLE EAST & AFRICA 350
14 COMPETITIVE LANDSCAPE 356
14.1 OVERVIEW 356
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 356
14.3 REVENUE ANALYSIS, 2021−2025 358
14.3.1 KEY VETERINARY CONTRACT RESEARCH ORGANIZATIONS 358
14.3.2 KEY VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 358

14.4 VETERINARY CRO MARKET SHARE ANALYSIS, 2025 359
14.4.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 360
14.4.2 RANKING OF KEY MARKET PLAYERS 361
14.4.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 362
14.4.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 363
14.5 VETERINARY CDMO MARKET SHARE ANALYSIS, 2025 363
14.5.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 364
14.5.2 RANKING OF KEY MARKET PLAYERS 365
14.5.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 366
14.5.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 367
14.6 COMPANY EVALUATION MATRIX: KEY VETERINARY CROS, 2025 367
14.6.1 STARS 367
14.6.2 EMERGING LEADERS 367
14.6.3 PERVASIVE PLAYERS 368
14.6.4 PARTICIPANTS 368
14.6.5 COMPANY FOOTPRINT: KEY VETERINARY CROS, 2025 369
14.6.5.1 Company footprint 369
14.6.5.2 Region footprint 369
14.6.5.3 Service footprint 370
14.6.5.4 Product type footprint 371
14.6.5.5 Animal type footprint 371
14.7 COMPANY EVALUATION MATRIX: VETERINARY CRO STARTUPS/SMES, 2025 372
14.7.1 PROGRESSIVE COMPANIES 372
14.7.2 RESPONSIVE COMPANIES 372
14.7.3 DYNAMIC COMPANIES 372
14.7.4 STARTING BLOCKS 372
14.7.5 COMPETITIVE BENCHMARKING: VETERINARY CRO STARTUPS/SMES, 2025 374
14.7.5.1 Detailed list of key veterinary CRO startups/SMEs 374
14.7.5.2 Competitive benchmarking of key veterinary CRO startups/SMEs 375
14.8 COMPANY EVALUATION MATRIX: VETERINARY CDMOS, 2025 375
14.8.1 STARS 376
14.8.2 EMERGING LEADERS 376
14.8.3 PERVASIVE PLAYERS 376
14.8.4 PARTICIPANTS 376
14.8.5 COMPANY FOOTPRINT: KEY VETERINARY CDMOS, 2025 378
14.8.5.1 Company footprint 378
14.8.5.2 Region footprint 378
14.8.5.3 Service footprint 379
14.8.5.4 Product type footprint 380
14.8.5.5 Animal type footprint 380
14.9 COMPANY EVALUATION MATRIX: VETERINARY CDMO STARTUPS/SMES, 2025 381
14.9.1 PROGRESSIVE COMPANIES 381
14.9.2 RESPONSIVE COMPANIES 381
14.9.3 DYNAMIC COMPANIES 381
14.9.4 STARTING BLOCKS 381
14.9.5 COMPETITIVE BENCHMARKING: VETERINARY CDMO STARTUPS/SMES, 2025 383
14.9.5.1 Detailed list of key veterinary CDMO startups/SMEs 383
14.9.5.2 Competitive benchmarking of key veterinary CDMO startups/SMEs 384
14.10 SERVICE COMPARATIVE ANALYSIS 385
14.11 COMPANY VALUATION & FINANCIAL METRICS 386
14.11.1 FINANCIAL METRICS 386
14.11.2 COMPANY VALUATION 386
14.12 COMPETITIVE SCENARIO 387
14.12.1 SERVICE LAUNCHES & APPROVALS 387
14.12.2 DEALS 388
14.12.3 EXPANSIONS 389
14.12.4 OTHER DEVELOPMENTS 390
15 COMPANY PROFILES 392
15.1 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 392
15.1.1 KEY PLAYERS 392
15.1.1.1 Argenta Holdco Limited 392
15.1.1.1.1 Business overview 392
15.1.1.1.2 Services offered 393
15.1.1.1.3 Recent developments 394
15.1.1.1.3.1 Service launches & upgrades 394
15.1.1.1.3.2 Deals 394
15.1.1.1.3.3 Expansions 395
15.1.1.1.4 MnM view 395
15.1.1.1.4.1 Key strengths 395
15.1.1.1.4.2 Strategic choices 395
15.1.1.1.4.3 Weaknesses & competitive threats 396
15.1.1.2 Aenova Group 397
15.1.1.2.1 Business overview 397
15.1.1.2.2 Services offered 398
15.1.1.2.3 Recent developments 399
15.1.1.2.3.1 Expansions 399
15.1.1.2.3.2 Other developments 401
15.1.1.2.4 MnM view 401
15.1.1.2.4.1 Key strengths 401
15.1.1.2.4.2 Strategic choices 401
15.1.1.2.4.3 Weaknesses & competitive threats 402
15.1.1.3 FAREVA SA 403
15.1.1.3.1 Business overview 403
15.1.1.3.2 Services offered 404
15.1.1.3.3 MnM view 405
15.1.1.3.3.1 Key strengths 405
15.1.1.3.3.2 Strategic choices 405
15.1.1.3.3.3 Weaknesses & competitive threats 405
15.1.1.4 Vetio 406
15.1.1.4.1 Business overview 406
15.1.1.4.2 Services offered 406
15.1.1.4.3 MnM view 408
15.1.1.4.3.1 Key strengths 408
15.1.1.4.3.2 Strategic choices 408
15.1.1.4.3.3 Weaknesses & competitive threats 408
15.1.1.5 TriRx Pharmaceutical Services 409
15.1.1.5.1 Business overview 409
15.1.1.5.2 Services offered 409
15.1.1.5.3 MnM view 410
15.1.1.5.3.1 Key strengths 410
15.1.1.5.3.2 Strategic choices 411
15.1.1.5.3.3 Weaknesses & competitive threats 411
15.1.1.6 Indian Immunologicals Ltd. 412
15.1.1.6.1 Business overview 412
15.1.1.6.2 Services offered 412
15.1.1.7 Recipharm AB 413
15.1.1.7.1 Business overview 413
15.1.1.7.2 Services offered 413
15.1.1.7.3 Recent developments 414
15.1.1.7.3.1 Technology launches 414
15.1.1.7.3.2 Deals 415
15.1.1.7.3.3 Expansions 415
15.1.1.7.3.4 Other developments 417
15.1.1.8 LABIANA 418
15.1.1.8.1 Business overview 418
15.1.1.8.2 Services offered 419
15.1.1.8.3 Recent developments 420
15.1.1.8.3.1 Other developments 420
15.1.1.9 Syngene International Limited 421
15.1.1.9.1 Business overview 421
15.1.1.9.2 Services offered 422
15.1.1.9.3 Recent developments 424
15.1.1.9.3.1 Deals 424
15.1.1.9.3.2 Other developments 425
15.1.1.10 CZ Vaccines 426
15.1.1.10.1 Business overview 426
15.1.1.10.2 Services offered 427
15.1.2 OTHER PLAYERS 428
15.1.2.1 AB7 Group 428
15.1.2.2 Kela Health 429
15.1.2.3 Eirgen Pharma 430
15.1.2.4 Bioingenium 431
15.1.2.5 Elise Biopharma 432
15.2 CONTRACT RESEARCH ORGANIZATIONS 433
15.2.1 KEY PLAYERS 433
15.2.1.1 Labcorp 433
15.2.1.1.1 Business overview 433
15.2.1.1.2 Services offered 434
15.2.1.1.3 Recent developments 435
15.2.1.1.3.1 Technology launches 435
15.2.1.1.3.2 Expansions 435
15.2.1.1.4 MnM view 436
15.2.1.1.4.1 Key strengths 436
15.2.1.1.4.2 Strategic choices 436
15.2.1.1.4.3 Weaknesses & competitive threats 436
15.2.1.2 Eurofins Scientific 437
15.2.1.2.1 Business overview 437
15.2.1.2.2 Services offered 438
15.2.1.2.3 Recent developments 439
15.2.1.2.3.1 Deals 439
15.2.1.2.4 MnM view 439
15.2.1.2.4.1 Key strengths 439
15.2.1.2.4.2 Strategic choices 440
15.2.1.2.4.3 Weaknesses & competitive threats 440
15.2.1.3 Charles River Laboratories 441
15.2.1.3.1 Business overview 441
15.2.1.3.2 Services offered 442
15.2.1.3.3 MnM view 443
15.2.1.3.3.1 Key strengths 443
15.2.1.3.3.2 Strategic choices 443
15.2.1.3.3.3 Weaknesses & competitive threats 444
15.2.1.4 Knoell Germany GmbH 445
15.2.1.4.1 Business overview 445
15.2.1.4.2 Services offered 445
15.2.1.4.3 Recent developments 447
15.2.1.4.3.1 Deals 447
15.2.1.4.4 Other developments 447
15.2.1.4.5 MnM view 447
15.2.1.4.5.1 Key strengths 447
15.2.1.4.5.2 Strategic choices 448
15.2.1.4.5.3 Weaknesses & competitive threats 448
15.2.1.5 Evotec 449
15.2.1.5.1 Business overview 449
15.2.1.5.2 Services offered 450
15.2.1.5.2.1 Deals 451
15.2.1.5.3 MnM view 451
15.2.1.5.3.1 Key strengths 451
15.2.1.5.3.2 Strategic choices 451
15.2.1.5.3.3 Weaknesses & competitive threats 452
15.2.1.6 KLIFOVET GmbH 453
15.2.1.6.1 Business overview 453
15.2.1.6.2 Services offered 454
15.2.1.7 Clinglobal 456
15.2.1.7.1 Business overview 456
15.2.1.7.2 Services offered 456
15.2.1.7.3 Recent developments 457
15.2.1.7.3.1 Service launches 457
15.2.1.7.3.2 Deals 458
15.2.1.7.3.3 Other developments 459
15.2.1.8 BioAgile Therapeutics Private Limited 460
15.2.1.8.1 Business overview 460
15.2.1.8.2 Services offered 460
15.2.1.9 Vetspin SRL 462
15.2.1.9.1 Business overview 462
15.2.1.9.2 Services offered 462
15.2.1.10 Veterinary Research Management 464
15.2.1.10.1 Business overview 464
15.2.1.10.2 Services offered 464
15.2.2 OTHER PLAYERS 466
15.2.2.1 Ridgeway Research Ltd. 466
15.2.2.2 Löhlein and Wolf Vet Research 467
15.2.2.3 Cebiphar 468
15.2.2.4 OCRvet 469
15.2.2.5 East Tennessee Clinical Research, Inc. 470

16 RESEARCH METHODOLOGY 471
16.1 RESEARCH DATA 471
16.2 RESEARCH METHODOLOGY DESIGN 471
16.2.1 SECONDARY DATA 471
16.2.1.1 Key data from secondary sources 472
16.2.2 PRIMARY DATA 473
16.2.2.1 Key data from primary sources 474
16.2.2.2 Key industry insights 475
16.3 MARKET SIZE ESTIMATION 477
16.3.1 BOTTOM-UP APPROACH 483
16.4 MARKET BREAKDOWN & DATA TRIANGULATION 485
16.5 MARKET SHARE ESTIMATION 486
16.5.1 RESEARCH ASSUMPTIONS 486
16.5.2 GROWTH RATE ASSUMPTIONS 486
16.6 RISK ASSESSMENT 487
16.7 RESEARCH LIMITATIONS 487
16.7.1 METHODOLOGY-RELATED LIMITATIONS 487
16.7.2 SCOPE-RELATED LIMITATIONS 487
17 APPENDIX 488
17.1 DISCUSSION GUIDE 488
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 493
17.3 CUSTOMIZATION OPTIONS 495
17.3.1 SERVICE ANALYSIS 495
17.3.2 COMPANY INFORMATION 495
17.3.3 GEOGRAPHIC ANALYSIS 495
17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 495
17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE 495
17.3.6 MARKET SHARE ANALYSIS, BY SERVICE (TOP 5 PLAYERS) 495
17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 495
17.4 RELATED REPORTS 496
17.5 AUTHOR DETAILS 497

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 47
TABLE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS 71
TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION) 75
TABLE 4 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023–2025 81
TABLE 5 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025 (USD PER KG) 82
TABLE 6 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025 (USD PER FINISHED UNIT) 82
TABLE 7 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025 (USD PER KG) 82
TABLE 8 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025 (USD PER FINISHED UNIT) 83
TABLE 9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
MAJOR CONFERENCES & EVENTS IN 2026–2027 83
TABLE 10 CASE STUDY 1: END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS 86
TABLE 11 CASE STUDY 2: END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB) 87
TABLE 12 CASE STUDY 3: END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS 87
TABLE 13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: MAJOR PATENTS 93
TABLE 14 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 98
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY
CDMOS & CROS 104
TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS 106
TABLE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 110
TABLE 21 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 22 KEY PLAYERS PROVIDING CRO SERVICES 112
TABLE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 113
TABLE 24 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 25 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DISCOVERY & PRE-CLINICAL STUDIES, BY COUNTRY, 2024–2031 (USD MILLION) 116
TABLE 26 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR VETERINARY CLINICAL TRIALS, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 27 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE, BY COUNTRY,
2024–2031 (USD MILLION) 120
TABLE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR REGULATORY AFFAIRS & CONSULTING, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 29 KEY PLAYERS PROVIDING CDMO SERVICES 123
TABLE 30 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 124
TABLE 31 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 32 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PROCESS API & FORMULATION DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 33 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 34 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PACKAGING & LABELING, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 35 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR QUALITY/STABILITY & POST-MARKET SUPPORT, BY COUNTRY,
2024–2031 (USD MILLION) 133
TABLE 36 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 135
TABLE 37 KEY PLAYERS PROVIDING VETERINARY MEDICINES 136
TABLE 38 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 136
TABLE 39 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 40 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 41 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 42 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN API/DRUG SUBSTANCE MANUFACTURING,
BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 43 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024–2031 (METRIC TONS) 142
TABLE 44 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 45 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 144
TABLE 46 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 144
TABLE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 48 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN API/DRUG SUBSTANCE MANUFACTURING,
BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 49 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024–2031 (METRIC TONS) 148
TABLE 50 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 51 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024–2031 (THOUSAND UNITS) 150
TABLE 52 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICATED FEED & SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 53 KEY PLAYERS PROVIDING VETERINARY MEDICAL DEVICES 152
TABLE 54 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 152
TABLE 55 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 56 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 58 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 59 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 161
TABLE 60 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 162
TABLE 61 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 62 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DOGS,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 63 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATS,
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 64 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR HORSES,
BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 65 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 66 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 172
TABLE 67 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 68 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATTLE,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 69 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SWINE,
BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 70 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 71 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SHEEP & GOATS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 72 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 73 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 184
TABLE 74 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MULTINATIONAL ANIMAL HEALTH COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 185
TABLE 75 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS, BY COUNTRY,
2024–2031 (USD MILLION) 187
TABLE 76 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR START-UPS & VETERINARY BIOTECH FIRMS, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 77 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 192
TABLE 78 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR
API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 193
TABLE 79 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 193
TABLE 80 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 194
TABLE 81 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 194
TABLE 82 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET BY COUNTRY, 2024–2031 (USD MILLION) 194
TABLE 83 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 195
TABLE 84 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 85 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 86 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 196
TABLE 87 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 88 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 89 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 90 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 91 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 197
TABLE 92 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 93 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 94 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 199
TABLE 95 US: KEY MACROINDICATORS 200
TABLE 96 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 200
TABLE 97 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 98 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 99 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 201
TABLE 100 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 101 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 102 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 103 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 104 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 203
TABLE 105 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 106 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 107 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 204
TABLE 108 CANADA: KEY MACROINDICATORS 205
TABLE 109 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE, 2024–2031 (USD MILLION) 205
TABLE 110 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 111 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 112 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 206
TABLE 113 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 114 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 115 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 116 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 117 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY ANIMAL TYPE, 2024–2031 (USD MILLION) 208
TABLE 118 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 119 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 120 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 209
TABLE 121 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 211
TABLE 122 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 211
TABLE 123 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 211
TABLE 124 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 212
TABLE 125 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 126 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE, 2024–2031 (USD MILLION) 212
TABLE 127 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 128 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 129 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 213
TABLE 130 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 131 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 132 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 133 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 134 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 215
TABLE 135 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 136 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 137 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 216
TABLE 138 GERMANY: KEY MACROINDICATORS 217
TABLE 139 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE, 2024–2031 (USD MILLION) 217
TABLE 140 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 141 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 142 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 218
TABLE 143 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 144 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 145 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 146 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 147 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY ANIMAL TYPE, 2024–2031 (USD MILLION) 220
TABLE 148 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 149 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 150 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 221
TABLE 151 UK: KEY MACROINDICATORS 222
TABLE 152 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 223
TABLE 153 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 154 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 155 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 224
TABLE 156 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 157 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 158 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 159 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 160 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 225
TABLE 161 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 162 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 163 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 226
TABLE 164 FRANCE: KEY MACROINDICATORS 227
TABLE 165 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 228
TABLE 166 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 167 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 168 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 229
TABLE 169 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 170 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 171 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 172 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 173 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 230
TABLE 174 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 175 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 176 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 231
TABLE 177 ITALY: KEY MACROINDICATORS 232
TABLE 178 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 233
TABLE 179 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 180 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 181 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 234
TABLE 182 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 183 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 184 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 185 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 186 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 235
TABLE 187 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 188 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 189 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 236
TABLE 190 SPAIN: KEY MACROINDICATORS 237
TABLE 191 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 238
TABLE 192 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 193 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 194 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 239
TABLE 195 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 196 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 197 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 198 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 199 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 240
TABLE 200 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 201 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 202 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 242
TABLE 203 NETHERLANDS: KEY MACROINDICATORS 243
TABLE 204 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 243
TABLE 205 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 206 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 207 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 244
TABLE 208 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 209 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 210 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 211 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 212 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 246
TABLE 213 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 214 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 215 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 247
TABLE 216 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 248
TABLE 217 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 218 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 219 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 249
TABLE 220 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 221 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 222 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 223 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 224 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 250
TABLE 225 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 226 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 227 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 251
TABLE 228 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 253
TABLE 229 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 254
TABLE 230 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 254
TABLE 231 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 254
TABLE 232 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 233 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 255
TABLE 234 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 235 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 236 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 256
TABLE 237 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 238 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 239 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 240 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 241 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 258
TABLE 242 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 243 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 244 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 259
TABLE 245 CHINA: KEY MACROINDICATORS 260
TABLE 246 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 260
TABLE 247 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 248 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 249 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 261
TABLE 250 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 251 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 252 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 253 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 254 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY ANIMAL TYPE, 2024–2031 (USD MILLION) 263
TABLE 255 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 256 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 257 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 264
TABLE 258 JAPAN: KEY MACROINDICATORS 265
TABLE 259 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY SERVICE, 2024–2031 (USD MILLION) 265
TABLE 260 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 261 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 262 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 266
TABLE 263 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 264 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 265 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 266 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 267 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 268
TABLE 268 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 269 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 270 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 269
TABLE 271 INDIA: KEY MACROINDICATORS 270
TABLE 272 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 271
TABLE 273 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 274 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 275 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 272
TABLE 276 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 277 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 278 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 279 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 280 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 273
TABLE 281 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 282 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 283 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 274
TABLE 284 AUSTRALIA: KEY MACROINDICATORS 275
TABLE 285 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 276
TABLE 286 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 287 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 288 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 277
TABLE 289 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 290 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 291 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 292 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 293 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 278
TABLE 294 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 295 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 296 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 279
TABLE 297 SOUTH KOREA: KEY MACROINDICATORS 280
TABLE 298 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 281
TABLE 299 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 300 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 301 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 282
TABLE 302 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 303 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 304 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 283
TABLE 305 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 306 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 283
TABLE 307 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 308 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 309 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 285
TABLE 310 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 286
TABLE 311 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 312 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 313 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 287
TABLE 314 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 315 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 316 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 317 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 318 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 288
TABLE 319 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 320 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 321 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 289
TABLE 322 NEW ZEALAND: KEY MACROINDICATORS 290
TABLE 323 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 291
TABLE 324 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 325 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 326 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 292
TABLE 327 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 328 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 329 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 330 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 331 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 293
TABLE 332 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 333 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 334 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 294
TABLE 335 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 295
TABLE 336 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 337 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 338 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 296
TABLE 339 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 340 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 341 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 342 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 343 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 298
TABLE 344 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 345 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 346 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 299
TABLE 347 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 300
TABLE 348 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 300
TABLE 349 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 300
TABLE 350 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 301
TABLE 351 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301
TABLE 352 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 301
TABLE 353 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 354 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 355 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 302
TABLE 356 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 357 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 358 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 359 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 360 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 304
TABLE 361 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 362 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 363 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 305
TABLE 364 BRAZIL: KEY MACROINDICATORS 306
TABLE 365 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 306
TABLE 366 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 367 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 368 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 307
TABLE 369 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 370 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 371 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 372 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 373 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 309
TABLE 374 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 375 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 376 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 310
TABLE 377 MEXICO: KEY MACROINDICATORS 311
TABLE 378 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 311
TABLE 379 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 380 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 381 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 312
TABLE 382 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 383 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 384 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 385 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 386 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 314
TABLE 387 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 388 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 389 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET,
BY END USER, 2024–2031 (USD MILLION) 315
TABLE 390 ARGENTINA: KEY MACROINDICATORS 316
TABLE 391 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 316
TABLE 392 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 393 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 394 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 317
TABLE 395 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 396 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 397 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 398 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 399 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 319
TABLE 400 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 401 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 402 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 320
TABLE 403 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 321
TABLE 404 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 405 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 406 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 322
TABLE 407 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 408 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 323
TABLE 409 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 323
TABLE 410 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 411 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 324
TABLE 412 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 413 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 414 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 325
TABLE 415 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 326
TABLE 416 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 326
TABLE 417 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 326
TABLE 418 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 327
TABLE 419 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 327
TABLE 420 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 327
TABLE 421 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 422 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 423 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 328
TABLE 424 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 425 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 329
TABLE 426 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 329
TABLE 427 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 428 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 330
TABLE 429 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 430 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 431 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 331
TABLE 432 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 332
TABLE 433 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 332
TABLE 434 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 435 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 333
TABLE 436 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 333
TABLE 437 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 333
TABLE 438 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 439 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 334
TABLE 440 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 441 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 335
TABLE 442 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 443 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 444 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 336
TABLE 445 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 337
TABLE 446 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 337
TABLE 447 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 448 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 449 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 338
TABLE 450 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 451 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 339
TABLE 452 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 453 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 454 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 340
TABLE 455 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE,
2024–2031 (USD MILLION) 340
TABLE 456 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE,
2024–2031 (USD MILLION) 340
TABLE 457 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 341
TABLE 458 UNITED ARAB EMIRATES: KEY MACROINDICATORS 342
TABLE 459 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 342
TABLE 460 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 461 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 462 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 343
TABLE 463 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 464 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 344
TABLE 465 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 344
TABLE 466 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 467 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 345
TABLE 468 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 469 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 470 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 346
TABLE 471 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 346
TABLE 472 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 473 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 474 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 347
TABLE 475 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 476 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 348
TABLE 477 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE,
2024–2031 (USD MILLION) 348
TABLE 478 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 479 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 349
TABLE 480 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 481 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 350
TABLE 482 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 350
TABLE 483 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 351
TABLE 484 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 351
TABLE 485 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 351
TABLE 486 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 352
TABLE 487 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 352
TABLE 488 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE,
2024–2031 (USD MILLION) 352
TABLE 489 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 353
TABLE 490 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 353
TABLE 491 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 353
TABLE 492 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE,
2024–2031 (USD MILLION) 354
TABLE 493 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE,
2024–2031 (USD MILLION) 354
TABLE 494 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 355
TABLE 495 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 356
TABLE 496 VETERINARY CONTRACT RESEARCH ORGANIZATIONS MARKET:
DEGREE OF COMPETITION 360
TABLE 497 VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS MARKET: DEGREE OF COMPETITION 364
TABLE 498 VETERINARY CRO MARKET: REGION FOOTPRINT 369
TABLE 499 VETERINARY CRO MARKET: SERVICE FOOTPRINT 370
TABLE 500 VETERINARY CRO MARKET: PRODUCT TYPE FOOTPRINT 371
TABLE 501 VETERINARY CRO MARKET: ANIMAL TYPE FOOTPRINT 371
TABLE 502 VETERINARY CRO MARKET: DETAILED LIST OF KEY VETERINARY CRO STARTUPS/SMES 374
TABLE 503 VETERINARY CRO MARKET: COMPETITIVE BENCHMARKING OF
KEY VETERINARY CRO STARTUPS/SMES 375
TABLE 504 VETERINARY CDMO MARKET: REGION FOOTPRINT 378
TABLE 505 VETERINARY CDMO MARKET: SERVICE FOOTPRINT 379
TABLE 506 VETERINARY CDMO MARKET: PRODUCT TYPE FOOTPRINT 380
TABLE 507 VETERINARY CDMO MARKET: ANIMAL TYPE FOOTPRINT 380
TABLE 508 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DETAILED LIST OF KEY VETERINARY CDMO STARTUPS/SMES 383
TABLE 509 VETERINARY CDMO MARKET: COMPETITIVE BENCHMARKING OF KEY VETERINARY CDMO STARTUPS/SMES 384
TABLE 510 VETERINARY CDMO & CRO MARKET: SERVICE LAUNCHES & APPROVALS, JANUARY 2022−NOVEMBER 2025 387
TABLE 511 VETERINARY CDMO & CRO MARKET: DEALS, JANUARY 2022−NOVEMBER 2025 388
TABLE 512 VETERINARY CDMO & CRO MARKET: EXPANSIONS,
JANUARY 2022−NOVEMBER 2025 389
TABLE 513 VETERINARY CDMO & CRO MARKET: OTHER DEVELOPMENTS,
JANUARY 2022-NOVEMBER 2025 390
TABLE 514 ARGENTA HOLDCO LIMITED: COMPANY OVERVIEW 392
TABLE 515 ARGENTA HOLDCO LIMITED: SERVICES OFFERED 393
TABLE 516 ARGENTA HOLDCO LIMITED: SERVICE LAUNCHES & UPGRADES,
JANUARY 2022−NOVEMBER 2025 394
TABLE 517 ARGENTA HOLDCO LIMITED: DEALS, JANUARY 2022–NOVEMBER 2025 394
TABLE 518 ARGENTA HOLDCO LIMITED: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 395
TABLE 519 AENOVA GROUP: COMPANY OVERVIEW 397
TABLE 520 AENOVA GROUP: SERVICES OFFERED 398
TABLE 521 AENOVA GROUP: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 399
TABLE 522 AENOVA GROUP: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 401
TABLE 523 FAREVA SA: COMPANY OVERVIEW 403
TABLE 524 FAREVA SA: SERVICES OFFERED 404
TABLE 525 VETIO: COMPANY OVERVIEW 406
TABLE 526 VETIO: SERVICES OFFERED 406
TABLE 527 TRIRX PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 409
TABLE 528 TRIRX PHARMACEUTICAL SERVICES: SERVICES OFFERED 409
TABLE 529 INDIAN IMMUNOLOGICALS LTD.: COMPANY OVERVIEW 412
TABLE 530 INDIAN IMMUNOLOGICALS LTD.: SERVICES OFFERED 412
TABLE 531 RECIPHARM AB: COMPANY OVERVIEW 413
TABLE 532 RECIPHARM AB: SERVICES OFFERED 413
TABLE 533 RECIPHARM AB: TECHNOLOGY LAUNCHES, JANUARY 2022−NOVEMBER 2025 414
TABLE 534 RECIPHARM AB: DEALS, JANUARY 2022−NOVEMBER 2025 415
TABLE 535 RECIPHARM AB: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 415
TABLE 536 RECIPHARM AB: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 417
TABLE 537 LABIANA: COMPANY OVERVIEW 418
TABLE 538 LABIANA: SERVICES OFFERED 419
TABLE 539 LABIANA: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 420
TABLE 540 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 421
TABLE 541 SYNGENE INTERNATIONAL LIMITED: SERVICES OFFERED 422
TABLE 542 SYNGENE INTERNATIONAL LIMITED: DEALS, JANUARY 2022−NOVEMBER 2025 424
TABLE 543 SYNGENE INTERNATIONAL LIMITED: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 425
TABLE 544 CZ VACCINES: COMPANY OVERVIEW 426
TABLE 545 CZ VACCINES: SERVICES OFFERED 427
TABLE 546 AB7 GROUP: COMPANY OVERVIEW 428
TABLE 547 KELA HEALTH: COMPANY OVERVIEW 429
TABLE 548 EIRGEN PHARMA: COMPANY OVERVIEW 430
TABLE 549 BIOINGENIUM: COMPANY OVERVIEW 431
TABLE 550 ELISE BIOPHARMA: COMPANY OVERVIEW 432
TABLE 551 LABCORP: COMPANY OVERVIEW 433
TABLE 552 LABCORP: SERVICES OFFERED 434
TABLE 553 LABCORP: TECHNOLOGY LAUNCHES, JANUARY 2022−NOVEMBER 2025 435
TABLE 554 LABCORP: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 435
TABLE 555 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 437
TABLE 556 EUROFINS SCIENTIFIC: SERVICES OFFERED 438
TABLE 557 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–NOVEMBER 2025 439
TABLE 558 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 441
TABLE 559 CHARLES RIVER LABORATORIES: SERVICES OFFERED 442
TABLE 560 KNOELL GERMANY GMBH: COMPANY OVERVIEW 445
TABLE 561 KNOELL GERMANY GMBH: SERVICES OFFERED 445
TABLE 562 KNOELL GERMANY GMBH: DEALS, JANUARY 2022–NOVEMBER 2025 447
TABLE 563 KNOELL GERMANY GMBH: OTHER DEVELOPMENTS,
JANUARY 2022−NOVEMBER 2025 447
TABLE 564 EVOTEC: COMPANY OVERVIEW 449
TABLE 565 EVOTEC: SERVICES OFFERED 450
TABLE 566 EVOTEC: DEALS, JANUARY 2022−NOVEMBER 2025 451
TABLE 567 KLIFOVET GMBH: COMPANY OVERVIEW 453
TABLE 568 KLIFOVET GMBH: SERVICES OFFERED 454
TABLE 569 CLINGLOBAL: COMPANY OVERVIEW 456
TABLE 570 CLINGLOBAL: SERVICES OFFERED 456
TABLE 571 CLINGLOBAL: SERVICE LAUNCHES, JANUARY 2022−NOVEMBER 2025 457
TABLE 572 CLINGLOBAL: DEALS, JANUARY 2022–NOVEMBER 2025 458
TABLE 573 CLINGLOBAL: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 459
TABLE 574 BIOAGILE THERAPEUTICS PRIVATE LIMITED: COMPANY OVERVIEW 460
TABLE 575 BIOAGILE THERAPEUTICS PRIVATE LIMITED: SERVICES OFFERED 460
TABLE 576 VETSPIN SRL: COMPANY OVERVIEW 462
TABLE 577 VETSPIN SRL: SERVICES OFFERED 462
TABLE 578 VETERINARY RESEARCH MANAGEMENT: COMPANY OVERVIEW 464
TABLE 579 VETERINARY RESEARCH MANAGEMENT: SERVICES OFFERED 464
TABLE 580 RIDGEWAY RESEARCH LTD.: COMPANY OVERVIEW 466
TABLE 581 LÖHLEIN AND WOLF VET RESEARCH: COMPANY OVERVIEW 467
TABLE 582 CEBIPHAR: COMPANY OVERVIEW 468
TABLE 583 OCRVET: COMPANY OVERVIEW 469
TABLE 584 EAST TENNESSEE CLINICAL RESEARCH, INC.: COMPANY OVERVIEW 470
TABLE 585 RISK ASSESSMENT ANALYSIS 487

LIST OF FIGURES

FIGURE 1 VETERINARY CONTRACT MANUFACTURING & RESEARCH
MARKET SEGMENTATION & REGIONAL SCOPE 45
FIGURE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2026 VS. 2031 (USD MILLION) 49
FIGURE 3 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION) 50
FIGURE 4 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION) 51
FIGURE 5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2026 VS. 2031 (USD MILLION) 51
FIGURE 6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2026 VS. 2031 (USD MILLION) 52
FIGURE 7 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2026 VS. 2031 (USD MILLION) 53
FIGURE 8 GEOGRAPHIC SNAPSHOT OF VETERINARY CROS MARKET 54
FIGURE 9 GEOGRAPHIC SNAPSHOT OF VETERINARY CDMOS MARKET 55
FIGURE 10 ADVANCEMENTS IN VETERINARY BIOLOGICS TO FUEL MARKET GROWTH 56
FIGURE 11 CDMO SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 57
FIGURE 12 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 58
FIGURE 13 ASIA PACIFIC TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 58
FIGURE 14 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 15 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 60
FIGURE 16 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
FIGURE 17 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
FIGURE 18 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
SUPPLY CHAIN ANALYSIS 77
FIGURE 19 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
VALUE CHAIN ANALYSIS 79
FIGURE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
ECOSYSTEM ANALYSIS 80
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85
FIGURE 22 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
INVESTMENT & FUNDING SCENARIO 86
FIGURE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–NOVEMBER 2025) 92
FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY PHARMACEUTICAL PATENTS (JANUARY 2014–NOVEMBER 2025) 93
FIGURE 25 AI USE CASES 97
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
VETERINARY CDMOS & CROS 104
FIGURE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 105
FIGURE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: GEOGRAPHIC SNAPSHOT 191
FIGURE 29 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT 210
FIGURE 30 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT 253
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CROS MARKET, 2021−2025 358
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CDMOS MARKET, 2021−2025 359
FIGURE 33 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 360
FIGURE 34 RANKING OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 361
FIGURE 35 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025) 362
FIGURE 36 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025) 363
FIGURE 37 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 364
FIGURE 38 RANKING OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 365
FIGURE 39 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025) 366
FIGURE 40 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025) 367
FIGURE 41 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 368
FIGURE 42 VETERINARY CRO MARKET: COMPANY FOOTPRINT 369
FIGURE 43 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 373
FIGURE 44 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 377
FIGURE 45 VETERINARY CONTRACT CDMO MARKET: COMPANY FOOTPRINT 378
FIGURE 46 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 382
FIGURE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: SERVICE COMPARATIVE ANALYSIS 385
FIGURE 48 EV/EBITDA OF KEY VENDORS 386
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 386
FIGURE 50 AENOVA GROUP: COMPANY SNAPSHOT (2024) 398
FIGURE 51 LABIANA: COMPANY SNAPSHOT (2024) 419
FIGURE 52 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025) 422
FIGURE 53 LABCORP: COMPANY SNAPSHOT (2024) 434
FIGURE 54 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 438
FIGURE 55 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 442
FIGURE 56 EVOTEC: COMPANY SNAPSHOT (2024) 450
FIGURE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET:
RESEARCH DESIGN 471
FIGURE 58 PRIMARY SOURCES 473
FIGURE 59 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 476
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 476
FIGURE 61 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 477
FIGURE 62 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 478
FIGURE 63 REVENUE SHARE ANALYSIS ILLUSTRATION: CHARLES RIVER LABORATORIES 478
FIGURE 64 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2025) 479
FIGURE 65 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CRO SERVICES 480
FIGURE 66 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CDMO SERVICES 481
FIGURE 67 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2026–2031) 482
FIGURE 68 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 482
FIGURE 69 TOP-DOWN APPROACH 483
FIGURE 70 BOTTOM-UP APPROACH 484
FIGURE 71 MARKET DATA TRIANGULATION METHODOLOGY 485

---

---